Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3290381 | 0.80 | TAAR1 (0.53) | IDO1TAAR1ALDH1A1LMNAMAPT | |
| SCHEMBL29500198 | 0.78 | IDO1 (0.66) | IDO1TAAR1ALOX5PTGS2ALDH1A1 | |
| SCHEMBL622754 | 0.78 | IDO1 (0.66) | IDO1TAAR1ALOX5PTGS2ALDH1A1 | |
| SCHEMBL39970 | 0.77 | TAAR1 (0.69) | IDO1TAAR1ALDH1A1LMNAMAPT | |
| SCHEMBL29633165 | 0.77 | TAAR1 (0.69) | IDO1TAAR1ALDH1A1LMNAMAPT | |
| SCHEMBL6319190 | 0.77 | HRH1 (0.52) | IDO1TAAR1KDM4ESLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL27792889 | 0.76 | IDO1 (0.69) | IDO1TAAR1ALOX5PTGS2ALDH1A1 | |
| SCHEMBL2782786 | 0.76 | TAAR1 (0.58) | IDO1TAAR1ALDH1A1LMNAMAPT | |
| SCHEMBL21233223 | 0.76 | CALM1 (0.44) | IDO1TAAR1ALOX5PTGS2ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL7689341 | 0.75 | TAAR1 (0.67) | IDO1TAAR1ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | VANDERBILT UNIVERSITY | 2023-11-16 | — | — | US | disclosed |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | VANDERBILT UNIVERSITY | 2023-11-09 | — | — | US | disclosed |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH, INC. | 2023-10-19 | — | — | US | disclosed |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | VANDERBILT UNIVERSITY (US) | 2023-07-11 | — | — | US | disclosed |
| US-11400103-B2 | Methods of preventing platelet activation | VANDERBILT UNIVERSITY (US) | 2022-08-02 | — | — | US | disclosed |
| US-20210023032-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH INC (US) | 2021-01-28 | — | — | US | disclosed |
| US-20200383938-A1 | COMPOUNDS AND METHODS FOR SCAVENGING DICARBONYL ELECTROPHILES | VANDERBILT UNIVERSITY | 2020-12-10 | — | — | US | disclosed |
| US-20200246358-A1 | METHODS OF PREVENTING PLATELET ACTIVATION | VANDERBILT UNIVERSITY | 2020-08-06 | — | — | US | disclosed |
| US-20200197323-A1 | METHODS FOR SUPPRESSING ACCUMULATION OF REFLUX-INDUCED PROTEIN ADDUCTS | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2020-06-25 | — | — | US | disclosed |
| US-20190314302-A1 | USE OF 2-HYDROXYBENZYLAMINE IN THE TREATMENT AND PREVENTION OF PULMONARY HYPERTENSION | VANDERBILT UNIVERSITY | 2019-10-17 | — | — | US | disclosed |
| US-20190247375-A1 | Prevention And Treatment Of Atrial Fibrillation/Flutter With Gamma-Ketoaldehyde Scavengers | VANDERBILT UNIVERSITY | 2019-08-15 | — | — | US | disclosed |
| US-20190099387-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH | 2019-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200383938-A1 | COMPOUNDS AND METHODS FOR SCAVENGING DICARBONYL ELECTROPHILES | OGG1, LGMN, GLO1 | IDO1 1729/4885TAAR1 4425/4885ALOX5 490/4885 |
| US-20190314302-A1 | USE OF 2-HYDROXYBENZYLAMINE IN THE TREATMENT AND PREVENTION OF PULMONARY HYPERTENSION | SIRT3, SIRT2, GLS | IDO1 720/4885TAAR1 3877/4885ALOX5 2790/4885 |
| US-20190247375-A1 | Prevention And Treatment Of Atrial Fibrillation/Flutter With Gamma-Ketoaldehyde Scavengers | KCNH1, AKR7A2, GLO1 | IDO1 1240/4885TAAR1 966/4885ALOX5 398/4885 |
| US-20210023032-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | IDO1 785/4885TAAR1 1641/4885ALOX5 351/4885 |
| US-20190099387-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | IDO1 785/4885TAAR1 1641/4885ALOX5 351/4885 |
| US-20200197323-A1 | METHODS FOR SUPPRESSING ACCUMULATION OF REFLUX-INDUCED PROTEIN ADDUCTS | FABP2, HSPBP1, FABP6 | IDO1 2660/4885TAAR1 1789/4885ALOX5 1191/4885 |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | HACL2, APOB, OAT | IDO1 4126/4885TAAR1 3700/4885ALOX5 1258/4885 |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | FABP2, SI, MLN | IDO1 608/4885TAAR1 4642/4885ALOX5 429/4885 |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | IDO1 785/4885TAAR1 1641/4885ALOX5 351/4885 |
| US-20200246358-A1 | METHODS OF PREVENTING PLATELET ACTIVATION | PLG, PLA2G7, PLAT | IDO1 4425/4885TAAR1 4702/4885ALOX5 291/4885 |
| US-11400103-B2 | Methods of preventing platelet activation | PLG, PLA2G7, PLAT | IDO1 4425/4885TAAR1 4702/4885ALOX5 291/4885 |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | OGG1, LGMN, GLO1 | IDO1 1729/4885TAAR1 4425/4885ALOX5 490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.